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The present study was carried out to evaluate the role of apoptotic proteins in REC-2006-mediated radiation protection in
hepatoma cell lines. REC-2006 treatment 2h before irradiation strongly inhibited the cleavage of ATM and PARP-1 in HepG2
cells. The expression of nuclear apoptosis inducing factor (AIF) was found to be more inhibited (∼1 7 % )i nH e p G 2c e l l si nR E C -
2006 + radiation-treated group. More inhibition (∼33%) of cytochrome c was observed in HepG2 cells upon REC-2006 treatment
2h prior irradiation. Similarly, signiﬁcantly more (P < .05) inhibition of Apaf-1, caspase-9 and caspase-3 was observed in REC-
2006 + radition-treated group in HepG2 cells. REC-2006 treatment restored the expression of ICAD in HepG2 cells; however, no
restorationwas observedinHep3Bcells.Lower nuclear tocytoplasmicCADratiowasobservedinHepG2cells (∼0.6)ascompared
with Hep3B cells (∼1.2) in REC-2006 + radiation-treated group. In conclusion, REC-2006 rendered higher protection in HepG2
cells by inhibiting the expression and translocation of AIF, inhibiting the cleavage of ATM and PARP-1, restoring the expression of
ICAD, inhibiting the release of cytochrome c and thus modulating the expression of Apaf-1 caspase-9 and activity of caspase-3.
1.Introduction
Exposure to ionizing radiation (IR) resulted in complex
physiological responses in the biological systems [1–3]. IR
is known to induce apoptosis [4, 5]. Damage to DNA is
considered as a major initiator of cellular response to IR [6].
The p53 gene is activated in response to DNA damage and
encodes a transcription factor [7] ,w h i c hi nt u r na c t i v a t e s
genesthatarrestcellgrowthand/orinduceapoptosis,thereby
preventing the propagation of genetically damaged cells. In
the absence of cellular stress, p53 protein is maintained at
low steady-state levels and exerts very little, if any, eﬀect
on the fate of the cell. However, in response to various
types of cellular stress, p53 protein is activated and this is
reﬂected in elevated protein levels, as well as augmented
biochemical capabilities. As a consequence of p53 activation,
cells can undergo marked phenotypic changes, ranging from
increased DNA repair to senescence and apoptosis [8].
The activation of the cysteine proteases with aspartate
speciﬁcity, termed caspases, is an extremely important step
in the execution of programmed cell death [9]. These
proteases are highly speciﬁc in their action and activate
or inhibit a variety of key protein molecules in the cell.
Strictly deﬁned, cell death can only be classiﬁed to follow
the classical apoptotic mode if execution of cell death is
dependent on caspase activity [9]. There are two relatively
well-characterized caspase cascades. One is initiated by the
activation of cell surface receptors, such as Fas and tissue
necrosis factors, leading to caspase-8 activation, which in
turn cleaves and activates downstream caspases such as
caspase-3, -6 and -7 [10]; and the other is triggered by
cytochrome c released from mitochondria, which promotes
the activation of caspase-9 through apoptosis protease acti-
vating factor-1 (Apaf-1) [11]. Apart from caspase-mediated
induction of apoptotic cell death, apoptosis inducing factor
(AIF) has also been shown as a main actor behind the
caspase-independent death pathway [12].
During apoptosis, the activated caspases are known to
cleave substrates such as Poly (ADP-ribose) polymerase
(PARP-1), actin, fodrin and lamin [13]. Caspase-3 has been2 Evidence-Based Complementary and Alternative Medicine
showntocleaveinhibitorofcaspase-activatedDNase(ICAD)
to inactivate its caspase-activated DNase (CAD)-inhibitory
eﬀect [13].
Ataxia Telanagiectasia Mutated (ATM) and PARP-1 are
two of the most important players in the cell’s response
to DNA damage. PARP-1 and ATM recognize and bind to
both single- and double-strand DNA breaks in response to
diﬀerenttriggers[14].ThecleavageofATMduringapoptosis
abrogatesitsproteinkinaseactivityagainstp53andgenerates
a kinase-inactive protein that acts through its DNA-binding
ability in a trans-dominant-negative fashion to prevent DNA
repair [15]. The ATM protein kinase is centrally involved in
the cellular response to IR and other DNA double-strand-
break-inducing insults.
PARP-1 is a nuclear enzyme, which is activated in
response to genotoxic insults by binding damaged DNA and
attaching polymers of ADP-ribose to nuclear proteins at the
expense of its substrate NAD+ [14]. The proteins respond
to DNA damage by transferring 50–200 molecules of ADP-
ribose to various nuclear proteins, including transcription
factors, histones and PARP-1 itself [16]. This poly(ADP-
ribosyl)ation activity of PARP-1 is important for main-
taining genomic integrity [17] and it has been associated
with longevity. Furthermore, PARP-1 is activated by agents
infringing single-stranded DNA damage such as alkylating
agents, IR and oxidative damage. Diverse apoptotic signals
for caspase activation converge at the mitochondria level,
provoking the release of cytochrome c, which participates
in the central control or executioner phase of the cell death
cascade [18, 19].
The release of cytochrome c triggers the formation
of a complex containing Apaf-1, a mammalian CED-4
homologue and procaspase-9, which is then auto-processed
and thereby capable of processing downstream eﬀector
p r o c a s p a s e ss u c ha sp r o c a s p a s e - 3[ 11]. The processing of
these caspases is followed by the cleavage of apoptotic
substrates, leading to the disruption of important cellular
processes, changes in cellular and nuclear morphology and
ultimately cell death [20].
Previously, we reported higher radioresistance against
γ-radiation in the HepG2 (p53++) cell lines as compared
with the Hep3B (p53−−) cell lines, indicating the plausible
role of p53 in radioresistance [2]. We demonstrated that a
non-polar chloroform fraction (REC-2006) of Podophyllum
hexandrum, a Himalayan plant which grows at an altitude
of about 4000m in the Himalayan region, rendered nearly
twicethesurvival(dosemodiﬁcationfactor(DMF)=1.72)in
p53 expressing HepG2 cells, as compared with p53-negative
H e p 3 Bc e l l s( 4 0 %s u r v i v a l ;D M F= 1.26) [2], mainly by
modulating the expression of p53. REC-2006 persuaded cell-
cyclearrestintheG1phase,encouragedcellproliferationand
DNArepairandthusrenderedsigniﬁcantlyhigherprotection
in the HepG2 cell line against acute γ-radiation. Conversely,
in the absence of p53, damaged DNA incorporated into the
next generation leading to cell death in the Hep3B cell line
[2]. We also reported a potent p53 inhibitor (piﬁthrin-α),
debilitated the radioprotective potential of REC-2006 in the
HepG2 cell line indicating the role of p53 protein in REC-
2006 mediated radioprotection [3]. To determine the eﬀect
of γ-radiation on HepG2 and Hep3B cells, colony formation
assay was used and ∼80% (P<. 05) mortality was observed
in HepG2 (p53++) cells at 10Gy (LD80 = 10Gy). Whereas,
a similar level (∼80%) of lethality was observed in Hep3B
(p53−−)c e l l sa t3 . 7G yo n l y( L D 80 = 3.7Gy). This was used
as study model. Previously we have reported that the most
optimal (maximum) survival (80%) was observed in HepG2
(p53++) cell line upon REC-2006 (10−5μgmL −1)t r e a t m e n t
2h before irradiation (10Gy) (LD80 = 10Gy). However, only
40% survival (maximum) was achieved at the same drug
concentration (10−5μgmL −1)a t3 . 7G y( L D 80 = 3.7Gy) in
the Hep3B cell line. With a view to further elucidating the
mode of action at molecular level, the present study was
carried out to investigate the expression pattern of apoptosis
regulatory proteins in REC-2006/γ-radiation-treated groups
in HepG2 and Hep3B cell lines with a view to decipher
the precise role of apoptotic proteins in REC-2006-mediated
radiation protection.
2. Methods
2.1. Reagents. T h er e a g e n t su s e dw e r eo fa n a l yt i c a lgra d ea n d
standard make. Culture medium, minimal essential medium
(MEM), antibiotics (penicillin G and streptomycin), trypsin
and fetal bovine serum (FBS) were procured from HiMedia,
India and Sigma Aldrich, USA. Mouse monoclonal anti-
bodies for the detection of human p53, ATM, PARP-1, AIF,
cytochrome c, caspase-3, caspase-9, ICAD, CAD and β-actin
proteins and alkaline phosphate-conjugated secondary anti-
mouse antibodies were procured from Santa Cruz Biotech
(Santa Cruz, CA, USA). Dithiothreitol (DTT), ethylene
diamine tetra-acetic acid (EDTA), PMSF, Nonidet P40
(NP-40), 5-bromo-4-chloroindol-3-yl phosphate/Nitro Blue
Tetrazolium (BCIP-NBT) reagent and protease inhibitors
were procured from Sigma Aldrich, St Louis, MO, USA.
Lysine, Tris-base and sodium dodecyl sulfate (SDS) were
obtained from Merck, Darmstadt, Germany, whereas nitro-
cellulose membrane was purchased from Millipore, USA.
2.2. Plant Extract. REC-2006 fraction was extracted from
rhizomes of Indian P. hexandrum as described earlier [1,
2]. Dried rhizomes of P. hexandrum Roylle growing at an
altitude of 4000m in the Himalayan region were procured
from the Defence Institute of High Altitude Research
(DIHAR), formerly Field Research Laboratory (Leh, Jammu
and Kashmir, India). Dried powder (10g per 100mL, w/v) of
P. hexandrum rhizome was extracted in a Soxhlet apparatus
thrice with diﬀerent solvents (1:6 ratio) of increasing
polarity namely, hexane, chloroform, alcohol, 50% alcohol
in water and water subsequently over the course of 24–
72h. The respective ﬁltrates were combined. All the extracts
were ﬁltered through Whatman ﬁlter paper no. 3, followed
by ﬁltration through a 0.22μm ﬁlter (Millipore, USA).
Extracts were than concentrated by solvent evaporation
underreducedpressureinarotaryevaporator(Buchi,Flawil,
Switzerland) and dried. Out of the ﬁve diﬀerent fractionated
extracts prepared, the dried chloroform extract (code name:
REC-2006) was used for the present study [2, 3].Evidence-Based Complementary and Alternative Medicine 3
2.3. Cell Culture. T h ec e l lc u l t u r es t u d i e sw e r ep e r f o r m e d
on human hepatoma cell lines. HepG2 (p53++, carrying
wild-type p53) and Hep3B (p53−− carrying p53 null)
cells were purchased from the National Centre for Cell
Science (NCCS), Pune, India. The cells were maintained as
monolayer culture in MEM (supplemented with 10% FBS,
100UmL−1 of penicillin, 100μgmL −1 of streptomycin, pH
7.4) at 37
◦C in a humidiﬁed 5% CO2 incubator (Binder,
Germany) in 25-cm2 culture ﬂasks (Nunc USA.) and were
sub-cultured twice a week. All experiments were performed
done when the cells reached about 70% conﬂuency.
2.4. Harvesting of Adherent Cells. Cells were harvested using
0.25% trypsin in Hank’s balanced salt solution (HBSS). After
removal of the medium, 1.0mL of chilled trypsin (0.25%)
was poured into the culture ﬂask (T25) and left for 30s
at room temperature. Excess trypsin, was decanted and the
culture ﬂasks were incubated at 37
◦C till the cells started
rollingoﬀ.Harvestedcellswerecountedandproperdilutions
were made by adding complete MEM medium to the cell
suspension for further experimentation.
2.5. Irradiation. Radiation was delivered using a 60Co
gamma chamber (Model 220, Atomic Energy of Canada
Ltd.) (dose rate of 43.8cGy/min). Cells were cultured in
culture ﬂasks (25cm2) and irradiated at their respective
LD80 radiation doses (HepG2: LD80 = 10Gy; Hep3B: LD80
= 3.7Gy). Culture ﬂasks ﬁtted with a ﬁlter cap (Nunc, USA)
were used to avoid the generation of hypoxic conditions in
the irradiation chamber [2].
2.6. Colonogenic Assay for Cell Survival. Cells (HepG2 and
Hep3B) harvested from exponentially grown cultures and
counted. Viability of cells was tested by dye exclusion test
(0.1% Trypan Blue). Nearly 300 cells were seeded in 60-mm
culture dishes (Tarsons, India) and incubated for 12h. The
attached cells were then treated with REC-2006, γ-radiation
and REC-2006 2h before γ-radiation. After treatments, the
cells were further incubated at 37
◦Cw i t h5 %C O 2 in a
humidiﬁed condition. Colonies appeared nearly 2 weeks of
incubation after and were counted. All experiments were
carried out in triplicate.
2.7. Experimental Plan. The experiment was divided into the
following four groups. Each group was in triplicates.
(1) Group I. Untreated control of HepG2 and Hep3B
cells.
(2) Group II. HepG2 and Hep3B cells treated with
10−5μg/mL) of REC-2006.
(3) Group III. HepG2 and Hep3B cells exposed to their
respective acute irradiation (HepG2: LD80 = 10Gy;
Hep3B: LD80 = 3.7Gy) [2].
(4) Group IV. HepG2 and Hep3B cells exposed to radi-
ation (respective LD80) 2h after REC-2006 (10−5μg
mL) treatment.
HepG2 and Hep3B cells were divided into the above
mentioned four treatment groups and after ﬁnal treatment,
cells were harvested at 8h for protein expression studies.
2.8. Extraction of Cytoplasmic and Nuclear Protein Fraction.
Cytoplasmic and nuclear protein fraction was extracted
as described earlier [2]. HepG2 and Hep3B cells were
harvested by trypsinization and centrifuged at 100g for
5min. The pellet was resuspended in 300μLo fb u ﬀer
A (50mM NaCl, 10mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) pH 8.0, 500mM sucrose,
1mM EDTA, 0.5mM spermidine, 0.15mM spermine, 0.2%
Triton X-100) containing β-mercaptoethanol and the pro-
tease inhibitors, that is, Phenylmethanesulfonyl ﬂuoride
(PMSF), leupeptin, aprotinin and pepstatin. After 15min
of incubation on ice, the suspension was centrifuged at
1400g for 10min. The supernatant (cytoplasmic fraction)
was collected and stored, whereas the pellet was washed
with 200μLb u ﬀer B (50mM NaCl, 10mM HEPES pH 8,
25% glycerol, 0.1mM EDTA, 0.5mM spermidine, 0.15mM
spermine)andthenresuspendedin100μLbuﬀerC(350mM
NaCl, 10mM HEPES, 25% glycerol, 0.1mM EDTA, 0.5mM
spermidine, 0.15mM spermine). After centrifugation at
17000g the supernatant (nuclear fraction) was collected and
stored at 4◦C[ 2].
2.9. Protein Estimation. Total soluble protein content in the
diﬀerent nuclear and cytoplasmic fractions were estimated
as described earlier [2, 21]. Brieﬂy, 10μL of the sample was
mixed with 90μL distilled water. After mixing thoroughly,
Bradford reagent (1.0mL) was added and absorbance was
recorded at room temperature within 20–30min at 595nm
using a micro-titer plate reader (Wallac, USA). The amount
(micrograms) of protein was quantiﬁed using BSA standard
curve.
2.10. SDS-PAGE Analysis of Proteins. For SDS-PAGE anal-
ysis, 10% polyacrylamide gels of 0.75mm thickness were
prepared, whereas for analysis of ATM and PARP-1, 7%
polyacrylamide gels of 0.75mm thickness were used. Protein
fractions were added to SDS-PAGE sample buﬀer (0.0625M
Tris-HCl, pH 6.8; 2% (w/v) SDS; 5% (v/v) glycerol; 2%
(v/v) 3-mercaptoethanol; 0.01% (w/v) bromophenol blue)
and heated in a boiling water bath for 2-3min. Equal
amount of protein samples (10μg) were loaded in each
well. Electrophoresis was carried out at a constant voltage
(stacking at 60V, resolving at 70V). After electrophoresis,
the gels were stained with gentle shaking in 0.1% coomassie
brilliant blue R-250 in methanol: glacial acetic acid: water
(4:2:4, v/v/v) at room temperature and destained in a
washing solution (methanol: acetic acid: water (1:0.7:8.3))
toobtaindistinctbandsoverclearbackground.Thegelswere
stored in 0.1% acetic acid for future analysis [2, 22].
2.11. Western Blot Analysis. Proteins were transferred elec-
trophoretically (100V, 1h) onto a nitrocellulose membrane
using a mini-trans blot assembly (Bio-Rad, Hercules, CA,
USA). The membrane was blocked in a blocking solution
(containing 5% w/v skimmed milk in TBS) for 2h at
room temperature. The expression levels of p53, ATM,
PARP-1, AIF, cytochrome c, caspase-3, caspase-9, ICAD,
CAD and β-actin were analyzed by probing with respective
mouse monoclonal antibodies (1:1000 dilution) having4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Eﬀect of optimal concentration of drug (REC-2006), that is, 10−5 μgmL −1 given 2h prior to irradiation (LD80 of respective cell
lines) on expression of (a) p53; (b) ATM in HepG2 and Hep3B cell lines. Single asterisk indicates signiﬁcant radiomodulatory activity
(increase/decrease in expression) in HepG2 cell lines, whereas double asterisks indicate the corresponding eﬀect in Hep3B cell lines with
respect to radiation (LD80) controls.
crossreactivitywithhumanproteins.Threewashesof15min
each in washing buﬀer (TBS, 0.2% Tween 20), were grown
and the membranes were incubated in TBS containing goat
anti-mouse IgG alkaline phosphate conjugated secondary
antibodies (1:10 000 dilution). The membranes were again
washed (three times for 15min) each with washing buﬀer
and then treated with BCIP-NBT reagent (Sigma, St Louis,
MO, USA) for 10–30min [23] followed by densitometric
analysis. The quantiﬁcation of individual protein bands was
done using Alpha Ease FC 4.0.0 Software (Alpha Innotech,
India). Relative expression of proteins was evaluated by
normalizing the expression of proteins with quantitative
housekeeping protein β-actin.
2.12. StatisticalAnalysis. Thedata is presentedasmean ± SD
of three separate experiments each performed in triplicate.
The statistical two-way analysis of variance (ANOVA) was
performed for multiple comparisons, followed by post hoc
test. Eﬀect of diﬀerent concentrations on survival of cell
lines was analyzed using Dunnet’s t- t e s tw i t ht w oc o n t r o l s
and ﬁve test values. Correlation analysis was performed to
evaluate various dose-dependent eﬀects. All the statistical
tests were performed using statistical software SPSS Version
11. Signiﬁcance was tested and P<. 05 was considered as
level of signiﬁcance.
3. Results
3.1.p53andATMExpressionAnalysis. Asigniﬁcant(P<. 05)
increase in the expression of p53 was observed in HepG2
(p53++) cells treated with REC-2006 alone (by 30 ± 3.7%)
and irradiation (by 73 ± 4.2%) as compared to untreated
control.However,REC-2006treatment2hbeforeirradiation
decreased (16 ± 2.75%) the expression of p53 as compared
with only irradiated group of HepG2 cell line (Figure 1(a),
lanes 3 and 4). As predicted, no expression of p53 was
observed in any treatment group of Hep3B (p53−−) cell line
(Figure 1(a)).
The expression of ATM (both fragment) increased in
radiation (+/− REC-2006) treatment group as compared to
untreated control of HepG2 (62%) as well as Hep3B (67%)
cell line. Treatment of γ-radiation produced more cleavage
product (249-kDa fragment) in Hep3B cell line as compared
with the HepG2 cell line (Figure 1(b),l a n e3 ) .H o w e v e r ,i n
a REC-2006 + radiation-treated group, more inhibition of
ATM cleavage was observed in HepG2 cells, as compared
with Hep3B cells (Figure 1(b),l a n e s3a n d4 ) .
3.2. Cytoplasmic and Nuclear PARP-1 Expression Analysis.
To determine the eﬀect of REC-2006 treatment on the
modulation of PARP-1 expression, in cytoplasm as well
in the nucleus, the cytoplasmic and nuclear proteins was
separated and analyzed independently. REC-2006 treatment
alone increased the expression of cytoplasmic PARP-1 in
HepG2 (∼23%) and Hep3B (∼20%) cells, as compared to
the respective untreated control (Figure 2(a),l a n e s1a n d
2). Caspase-mediated cleavage of cytoplasmic PARP-1 was
observed in both cell lines in the radiation-treated groups.
More inhibition in nuclear translocation of fragmented
PARP-1 (89kDa) was observed in HepG2 cell line, as com-
pared with Hep3B cell line when REC-2006 treatment was
given 2h before irradiation. Inhibition of caspase-mediated
cleavage of PARP-1 (89kDa) was observed when REC-2006
was treated 2h before irradiation in HepG2 and Hep3B
cells. In radiation (−2h REC-2006) treatment group, intact
(116kDa) to cleaved (89kDa) PARP-1 ratio was observed toEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Eﬀect of optimal concentration of drug (REC-2006), that is, 10−5 μgmL −1 given 2h prior to irradiation (LD80 of respective cell
lines) on expression of (a) cytoplasmic PARP-1; (b) nuclear PARP-1 in HepG2 and Hep3B cell lines. Single asterisk indicates signiﬁcant
radiomodulatory activity (increase/decrease in expression) in HepG2 cell lines, whereas double asterisk indicate the corresponding eﬀect in
Hep3B cell lines with respect to radiation (LD80) controls.
be much higher in nuclear fraction of HepG2 cells (∼3.3) as
compared with Hep3B cells (∼0.91) (Figure 2(b),l a n e4 ) .
3.3. Cytoplasmic and Nuclear AIF Expression Analysis. REC-
2006 treatment alone rendered no considerable eﬀect on
the expression of cytoplasmic AIF HepG2 and Hep3B
cell lines, when compared with their respective untreated
control groups (Figure 3(a), lanes 1 and 2). No expression
of nuclear AIF was observed in untreated and REC-2006
treated HepG2 and Hep3B cell lines (Figure 3(b),l a n e s1
and 2). Expression of cytoplasmic AIF was strongly inhibited
(∼50% decrease) in HepG2 (p53++) cells pretreated with
REC-2006 2h before irradiation as compared with irradiated
control (Figure 3(a),l a n e s3a n d4 ) .H o w e v e r ,t h ed e g r e e
of inhibition was relatively less (∼10% decrease) in the
respective treatment group of Hep3B cell line (Figure 3(a),
lanes 3 and 4). Similarly, the expression of nuclear AIF
was found to be inhibited in HepG2 cell line (∼17%), as
compared with Hep3B cell line (∼11%) in REC-2006 +
radiation-treated group, and also when compared with their
respectiveradiation-onlytreatmentgroup(Figure 3(b),lanes
3a n d4 ) .
3.4. Modulation of Cytochrome c, Apaf-1, Caspase-9 and
Caspase-3. A decrease in the expression of cytochrome c
was observed in REC-2006 pre-treated (−2h) irradiated
group as compared with only irradiated group of both
HepG2 and Hep3B cells. However, higher inhibition of
cytochrome c was observed in HepG2 cells (∼33% decrease)
as compared with Hep3B cells (∼24% decrease) upon REC-
2006 treatment 2h prior irradiation (Figure 4(a),l a n e s3a n d
4). No expression of cytochrome c was observed in REC-
2006 treated and untreated control group of HepG2 and
Hep3B cells (Figure 4(a), lanes 1 and 2). Similarly higher
inhibition of Apaf-1 was observed in HepG2 cells (∼40%
decrease) as compared with Hep3B cells (∼19% decrease)
upon REC-2006 treatment 2h prior irradiation (Figure 4(b),
lanes 3 and 4). However, no expression of Apaf-1 was
observed in untreated control and REC-2006-treated group
o fH e p G 2a sw e l la sH e p 3 Bc e l l s( Figure 4(b),l a n e s3a n d
4). Similarly, no expression of caspase-9 was observed in
untreated control and REC-2006-treated group of HepG2
as well as Hep3B cells. A substantial decrease in caspase-9
expression was observed in HepG2 cells (∼14% decrease)
as compared with Hep3B cells (∼8% decrease) when REC-
2006 treatment was given 2h prior irradiation (Figure 4(c),
lanes 3 and 4). The expression of caspase-3 decreased upon
REC-2006 (−2h) + radiation-treated group as compared
with irradiated group in both HepG2 and Hep3B cell lines.
However, higher inhibition of caspase-3 was observed in
HepG2 cells (∼84% decrease) as compared with Hep3B cells
(∼62% decrease) upon REC-2006 treatment 2h prior to
irradiation (Figure 4(d), lanes 3 and 4). No expression of
caspase-3 was observed in REC-2006-treated and untreated
control group of HepG2 and Hep3B cells (Figure 4(d),l a n e s
1a n d2 ) .
3.5. Modulation of Cytoplasmic ICAD and Cytoplasmic and
Nuclear CAD. The expression of cytoplasmic ICAD was
found to be inhibited in radiation-treated cancers group as
compared with untreated control in HepG2 as well as Hep3B
cells. However, REC-2006 treatment 2h prior irradiation
signiﬁcantly (P<. 05) restored the expression of ICAD in6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀect of optimal concentration of drug (REC-2006), that is, 10−5 μgmL −1 given 2h prior to irradiation (LD80 of respective
cell lines) on expression of (a) cytoplasmic AIF; (b) nuclear AIF in HepG2 and Hep3B cell lines. Single asterisk indicates signiﬁcant
radiomodulatory activity (increase/decrease in expression) in HepG2 cell lines, whereas double asterisks indicate the corresponding eﬀect in
Hep3B cell lines with respect to radiation (LD80) controls.
HepG2 cells. However, no REC-2006-mediated restoration
o fI C A Dw a so b s e r v e di nH e p 3 B( Figure 5(a),l a n e4 ) .A n
inhibition in the expression of cytoplasmic as well as nuclear
CAD was observed in HepG2 as well as Hep3B cells treated
with REC-2006 (−2h) + radiation as compared with only
irradiated control groups (Figures 5(b) and 5(c),l a n e s3a n d
4). In a REC-2006 (−2h) + irradiation treatment group,
lower nuclear to cytoplasmic CAD ratio was observed in
HepG2 cells (∼0.6) as compared with Hep3B cells (∼1.2).
Lower nuclear to cytoplasmic CAD ratio indicated the REC-
2006-mediatedinhibitionofnucleartranslocationofCADin
HepG2 cells (Figures 5(b) and 5(c),l a n e4 ) .
4. Discussion
During the course of evolution, cells have evolved various
sophisticated pathways to sense and overcome DNA damage
as a mechanism to preserve the integrity of the genome.
Radiation and/or environmental toxins induce spontaneous
DNA lesions, trigger checkpoint activation and consequent
cell-cycle arrest leading to DNA repair or apoptosis. Expo-
sure to IR results in the activation of complex signal
transduction pathways, which determine response of cells
and organisms. Diﬀerences in cell type, interindividual
geneticdiﬀerencesandcrosstalkoccurringbetweensignaling
pathways help to channelize radiation stress signals between
cell-cycle delay, enhanced DNA repair and apoptosis [6].
The discovery of the p53 tumor suppressor gene initiated a
plethora of investigation primarily to understand the basic
biology behind its role in maintaining genomic stability
and cellular response to DNA damage. p53 is one of the
most commonly mutated genes in human cancers [6]a n d
its product is a multifunctional protein that regulates sev-
eral physiological processes including cell-cycle checkpoints,
apoptosis and DNA repair [24].
Podophyllum hexandrum Royle, a high altitude
Himalayan medicinal plant is being used since ancient
times in the Indian and Chinese systems of medicine
for the treatment of various diseases and disorders and
its radioprotective properties of P. hexandrum have been
established in our institute recently [2, 3, 5, 21–23, 25–
32]. REC-2006 contains 4-demethylpodophyllotoxin,
podophyllotoxin glycoside, epi-podophyllotoxin and
podophyllotoxin [29]. It has been reported earlier that aryl-
tetralin lignan content inﬂuences the radiation protective
potential of the Podophyllum fractions to a great extent [30].
We earlier reported that REC-2006 modulated the
expression of p53 and thereby persuaded cell-cycle arrest
in the G1 phase, encouraged cell proliferation and DNA
repair and thus rendered signiﬁcantly higher protection in
the HepG2 cell line against acute γ-radiation. Conversely,
Singh and co-workers reported the LD80 (80% death) of
HepG2 cell at the dose of 10Gy (dose rate of 43.8cGymin−1)
[2]. In order to simulate the same eﬀect of radiation in
Hep3B cells, we took LD80 of Hep3B cell (3.7Gy: dose rate
43.8cGymin−1) as a radiation control for Hep3B cells. It has
been reported that in the absence of p53, damaged DNA was
incorporated into the next generation leading to cell death in
the Hep3B cell line [2]. The present study was carried out in
continuation to investigate the role of apoptotic proteins in
REC-2006 mediated radiation protection.Evidence-Based Complementary and Alternative Medicine 7
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Figure 4: Eﬀect of optimal concentration of drug (REC-2006), that is, 10−5 μgmL −1 given 2h prior to irradiation (LD80 of respective
cell lines) on expression of (a) cytochrome c; (b) Apaf-1; (c) caspase-9; (d) caspase-3 in HepG2 and Hep3B cell lines. Single asterisk
indicates signiﬁcant radiomodulatory activity (increase/decrease in expression) in HepG2 cell lines, whereas double asterisks indicate the
corresponding eﬀect in Hep3B cell lines with respect to radiation (LD80) controls.
A signiﬁcant increase in the expression of p53 was
observed in the HepG2 (p53++) cells treated with REC-
2006 alone as compared to the untreated control. However,
REC-2006 treatment 2h before irradiation decreased the
expression of p53 as compared with the irradiated-only
group of the HepG2 cell line, indicating the role of p53
in radiation protection. Treatment of γ-radiation produced
more ATM cleavage product (240-kDa fragment) in the
Hep3B cell line as compared with the HepG2 cell line.
Inhibition of ATM cleavage as observed in HepG2 cells in
a REC-2006 + radiation-treated group, suggested the role
of ATM in REC-2006-mediated activation of p53 leading to
radiation protection, however ATM may have a diﬀerent role
in the p53-deﬁcient Hep3B cell line. Role of ATM protein in
radiation protection can also be corroborated by the earlier
ﬁnding, which demonstrates that AT cells are hypersensitive
to DNA damaging agents, such as γ-radiation and restriction
enzyme digestion that can introduce double-stranded DNA
breaks [33]. ATM is also responsible for signaling p35-
mediated cell-cycle arrest. We earlier demonstrated the REC-
2006-mediated G1 phase arrest in the p53 carrying HepG2
cell line leading to higher radiation protection [2].8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀect of optimal concentration of drug (REC-2006), that is, 10−5 μgmL −1 given 2h prior to irradiation (LD80 of respective cell
lines) on expression of (a) ICAD; (b) cytoplasmic CAD; (c) nuclear CAD in HepG2 and Hep3B cell lines. Asterisk indicates signiﬁcant
radiomodulatory activity (increase/decrease in expression) in HepG2 cell lines, whereas double asterisks indicate the corresponding eﬀect in
Hep3B cell lines with respect to radiation (LD80) controls.
Increase in the expression of cytoplasmic PARP-1 in
HepG2 and Hep3B cells as compared with the respective
untreated control indicated the induction of PARP-1 by
REC-2006. Intact (116kDa) to cleaved (89kDa) PARP-1
r a t i ow a sm u c hh i g h e ri nn u c l e a rf r a c t i o no fH e p G 2c e l l s
as compared with Hep3B cells (∼0.91) in the radiation
(−2h REC-2006) treatment group indicating that REC-
2006 inhibits the nuclear translocation of cleaved (89-kDa)
PARP-1 in HepG2 cells. Furthermore, REC-2006-mediated
induction of cytoplasmic PARP-1 might have inhibited the
ATM kinase activity in response to DNA damage. Earlier
ﬁndings that demonstrate the modulation of the ATM
signaling network by a novel poly(ADP-ribose)-dependent
pathway [34] and poly(ADP-ribose)polymerase-1-mediated
inhibition of ATM kinase activity in response to DNA
damage [35] support the present ﬁnding. Again ATM and
PARP-1 participate in distinct forms of DNA repair that
partially compensate for each other. PARP-1 and ATM
participate in base excision repair (BER) and homologous
recombination (HR), respectively [14]. In vitro,c e l lc u l t u r e
and ex vivo studies show that poly(ADP-ribosyl)ation plays
a critical role in the survival and maintenance of genomic
stability of proliferating cells exposed to low or moderate
levels of DNA-damaging agents [16].
Expression of cytoplasmic AIF was strongly inhibited
in HepG2 (p53++) cells pretreated with REC-2006 2hEvidence-Based Complementary and Alternative Medicine 9
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Figure 6:Theschematichypotheticaldiagramexplainstheγ-radiation-inducedapoptoticandtheREC-2006-mediatedradiationprotection
pathway.
before irradiation as compared to the irradiated control,
suggesting the REC-2006-mediated inhibition of apoptosis
in the HepG2 cell line. Increase in the expression of HSP
in REC-2006 + radiation-treated group of the HepG2 cell
line [2] supports the present ﬁnding. Ravagnan and his co-
workers have already demonstrated the antagonistic relation
between Hsp and AIF [36]. Similarly, the expression of
nuclear AIF was found to be inhibited more in the HepG2
cell line as compared with the Hep3B cell line in the REC-
2006 + radiation-treated group indicated that induction of
Hsp70 in REC-2006 + radiation-treated group of the HepG2
cell line might have inhibited the nuclear translocation of
AIF leading to inhibition of apoptosis. Inhibition of nuclear
import of AIF to avoid DNA fragmentation in TF-1 cell has
been reported earlier [37].
However, higher inhibition of cytochrome c and AIF as
observed in the HepG2 cells and the Hep3B cells upon REC-
2006 treatment 2h prior irradiation suggests that REC-2006
inhibited the mitochondrial release of cytochrome c and AIF
in the HepG2 cell line. The loss of Δψm accompanies the
release of cytochrome c and AIF into the cytosol, which
respectively triggers caspase-dependent and independent
DNAfragmentation[37].Podophyllumhexandrummediated
stabilization of mitochondrial membrane stabilization has
been reported earlier [29]. Similarly, higher inhibition of
Apaf-1 and caspase-9 expression observed in HepG2 cells
in REC-2006 + radiation-treated group indicated that REC-
2006 might have inhibited the caspase-9 by inhibiting the
mitochondria release of cytochrome c and induction of
Apaf-1. Cytochrome c has been shown to promote caspase-
9 activation by inducing nucleotide binding to Apaf-1
[38]. Inhibition of caspase-3 observed in HepG2 cells as
compared with Hep3B cells upon REC-2006 treatment 2
h prior irradiation supported the inhibition of caspase-9.
Furthermore, inhibition of caspase-3 in the REC-2006 +
radiation-treated group of the HepG2 cell line also supports
the REC-2006 mediated inhibition of ATM and PARP-1
cleavage in the respective treatment group.
The expression of cytoplasmic ICAD was inhibited in the
radiation-treated group as compared to untreated control
in HepG2, as well as Hep3B cells. However, REC-2006
treatment 2h prior to irradiation signiﬁcantly restored the
expression of ICAD in HepG2 cells. Inhibited expression
o fc y t o p l a s m i ca sw e l la sn u c l e a rC A Do b s e r v e di nH e p G 2
cells treated with REC-2006 (−2h) + radiation supports the
restoration of ICAD in the HepG2 cell line. No REC-2006-
mediated restoration of ICAD as observed in the Hep3B
cell line explains the higher expression of CAD in the
Hep3B cell line leading to apoptotic cell death. Restoration
of ICAD in the HepG2 cell line further supports the lower
nuclear to cytoplasmic CAD ratio in HepG2 cells as observed
in the REC-2006 (−2h) + irradiation treatment group of
the HepG2 cell line. Lower expression of nuclear CAD
and restoration of cytoplasmic ICAD explain the lower
degradation of nuclear DNA as observed earlier in the
HepG2 cell line.
In conclusion, REC-2006 renders higher protection to
the HepG2 cell line by inhibiting the expression of p53 and
AIF,inhibitingthecleavageofATMandPARP-1,andalsothe
release of cytochrome c and thus modulating the expression
of Apaf-1 and caspase-9 leading to inhibition of caspase-
3 activities. Furthermore, REC-2006 treatment restores the10 Evidence-Based Complementary and Alternative Medicine
expression of ICAD and inhibits the nuclear translocation of
CAD and AIF leading to inhibition of DNA degradation and
apoptosis. The absence of REC-2006-mediated restoration
of ICAD and lower inhibition of mitochondrial release of
cytochrome c might have induced DNA fragmentation and
apoptosis that ultimately led to lower radiation protection in
theHep3Bcellline.Figure 6explainstheγ-radiationinduced
apoptotic pathways and the role of REC-2006 in modulation
ofapoptotic proteinsleadtoradioprotection. Furtherstudies
for inhibiting and activating the expression of p53 in the
HepG2 cell line and transfecting the p53 gene in the p53
negative Hep3B cell line are intended to be carried out in
future to validate the present observations.
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